Uncategorized
Valeant Pharmaceuticals names interim CEO
Valeant Pharmaceuticals International announced in a press release that it has appointed Howard B. Schiller as interim CEO.Schiller was Valeant’s chief financial officer from December 2011 through June 2015 and has served on Valeant’s Board of Directors since 2012, according to the release. J. Michael Pearson, Valeant’s CEO, is on medical leave of absence and remains in the hospital where he is being treated for pneumonia, and the timing of his expected return is uncertain, the release stated.